16-Dec-2025
No headlines found.
No press releases found.
No news found.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.
Forian trades on the NASDAQ stock market under the symbol FORA.
As of December 16, 2025, FORA stock price climbed to $2.14 with 21,437 million shares trading.
FORA has a beta of 0.72, meaning it tends to be less sensitive to market movements. FORA has a correlation of 0.03 to the broad based SPY ETF.
FORA has a market cap of $66.49 million. This is considered a Micro Cap stock.
Last quarter Forian reported $8 million in Revenue and $.00 earnings per share. This beat revenue expectation by $351,400 and exceeded earnings estimates by $.01.
In the last 3 years, FORA traded as high as $5.45 and as low as $1.64.
The top ETF exchange traded funds that FORA belongs to (by Net Assets): VTI, VXF, IWC, DFAC, DFSU.
FORA has underperformed the market in the last year with a price return of +7.0% while the SPY ETF gained +13.1%. FORA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -4.0% and -2.7%, respectively, while the SPY returned +3.1% and -0.4%, respectively.
FORA support price is $2.07 and resistance is $2.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FORA shares will trade within this expected range on the day.
